Economics

TAG overview

Net sales, operating result (EBIT) and research and development costs, by business sector¹

€ million

Life Science

Healthcare

Electronics

Group

2021

Net sales²

8,992

7,089

3,606

19,687

Operating result (EBIT)²

2,480

1,823

508

4,179

R&D costs³

351

1,712

278

2,426

2022

Net sales

10,380

7,839

4,013

22,232

Operating result (EBIT)

2,808

1,895

572

4,474

R&D costs³

399

1,694

308

2,521

1	As a non-operating segment, Corporate and Other is not shown here as a separate item, but rather under Segment Reporting in our 2022 Annual Report (p. 247-251).
2	2021 figures have been adjusted due to product reallocations between the Life Science and Electronics business sectors.
3	Not presented are research and development costs of € 119 million (2021: € 85 million) allocated to Corporate and Other. The 2021 figure has been adjusted due to a change in functional allocation between administration expenses, research and development costs as well as other operating expenses.